Effects of insulin on placental, fetal and maternal outcomes in gestational diabetes mellitus

Pakistan Journal of Medical Sciences

Volumn 30, Issue 2, 2014, Pages 240-244

  Arshad, Rabia ^a   Karim, Nasim ^a   Hasan, Jahan Ara ^b  

^a BAHRIA UNIVERSITY   (Pakistan)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

Fetal outcome; Gestational diabetes; Gross morphology; Insulin; Maternal outcome; Placenta

Indexed keywords

INSULIN; NPH INSULIN PLUS REGULAR INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; BODY WEIGHT; CESAREAN SECTION; CLINICAL ARTICLE; COMPLETENESS OF MEMBRANES; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORD COLOR; DIET THERAPY; FEMALE; FETUS OUTCOME; FIBRINOID NECROSIS; HUMAN; KINESIOTHERAPY; LENGTH OF THE CORD; MATERNAL OUTCOME; NECROSIS; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PLACENTA CONSISTENCY; PLACENTA SHAPE; PLACENTA SIZE; PLACENTA WEIGHT; PLACENTAL OUTCOME; PREGNANCY DIABETES MELLITUS; SCREENING; BIRTH WEIGHT; BLOOD GLUCOSE MONITORING; DIABETIC DIET; DRUG EFFECT; EVENING DOSAGE; EXERCISE; FETUS DEATH; HUMAN TISSUE; INSULIN TREATMENT; MEMBRANE COMPLETENESS; MORNING DOSAGE; MULTICENTER STUDY; ORAL GLUCOSE TOLERANCE TEST; PLACENTAL CONSISTENCY; PLACENTAL SHAPE; PLACENTAL SIZE; POSTPRANDIAL STATE; PREGNANCY OUTCOME; SECOND TRIMESTER PREGNANCY; STILLBIRTH; THIRD TRIMESTER PREGNANCY; TISSUE NECROSIS; UMBILICAL CORD; UMBILICAL CORD COLOR; UMBILICAL CORD WIDTH; VAGINAL DELIVERY;

EID: 84896853827     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.302.4396     Document Type: Article

References (25)

1. Serlin DC, Lash RW. Diagnosis and management of gestational diabetes. Am Fam Physician. 2009;80(1):57-62.
2. Colomiere M, Permezel M, Riley C, Desoye G, Lappas M. Defective insulin signaling in placenta from pregnancy complicated by gestational diabetes mellitus. Euro J Endocrinol. 2009;160:567-578. doi: 10.1530/EJE-09-0031
3. World Health Organization 1999. Definition, diagnosis and classification of diabetes Mellitus and its complications Part 1. Provisional report of a WHO Consultant. Diabetes Medicines. 1999;15(7):539-553.
4. Madazal R, Tuten A, Calary Z, Uzun H, Uludag S, Ocak V. Incidence of Placental Abnormalities, maternal and cord Plasma Malondialdehyde and Vascular Endothelial Growth Factors Levels in Women with Gestational Diabetes Mellitus and Non diabetic controls. Gynecol Obstet Invest. 2008;65(4):227-232. doi: 10.1159/0001 13045.
5. Akhter F, AnjumanBano ML, Ferdaus R. Effects of gestational diabetes mellitus on gross morphological structure of preterm placenta. Bangladesh J Anat. 2010;8(1):34-38.
6. Fowden L, Forhead J, Coan PM, Burton GJ. The placenta and intrauterine programming. J Neuroendocrinol. 2008;20(4):439-450.
7. Leach L, Taylor A, Sciota F. Vascular dysfunction in the diabetic placenta: cause and consequences. J Anat. 2009;215:69-76. doi: 10.1111/J.1469-7580.2009.01098.x
8. Mento. G, Bo S, Signorile A, Gallio ML, Cotrino I, Poala C et al. Current management of gestational diabetes mellitus. Expert Rev Obstet Gynecol. 2008;3(1):73-79.
9. thedition)". Katzung(ed), MacgrawHill. USA: 2007:684-686.
10. Nicholcon W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. Benefits and risks of oral diabetic agents compared with insulin in women with Gestational Diabetes Mellitus: A systemic review. Obstet Gynecol. 2009;113(1):206-17.
11. Mumtaz M. Gestational diabetes mellitus. Malaysian J Med Sci. 2000;7(1):4-9.
12. Samad NJ, Hassan JA, Shera AS, Maqsood A. Gestational Diabetes Mellitus: Screening in a developing country. J Pak Med Assoc. 1996;46(11):249-252.
13. Veciana MD, Major CA, Morgan MA, Asart T, Tookey JS, Lien JM, et al. Post prandial versus pre-prandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Eng J Med. 1995;333(19):1237-1241.
14. Debella D, Snell-Bergeon JK, Hartsfield CL, Bischoff JK, Hamman RF, McDuffie RS. Increasing prevalence of gestational diabetes mellitus over time and by birth cohort. Diabetes Care. 2005;28:579-584.
15. Boyd PA, Scott AK, Keeling JW. Quantitative structural studies, on placentas from pregnancies complicated by diabetes mellitus. Br J Obstet Gynaecol. 1986;93:31-35.
16. Mayhew TM, Sorensen FB, Klebe JG, Jackson MR. The effects of mode of delivery and sex of new born on placental morphology in control and diabetic pregnancies. J Anat. 1993;183:545-552.
17. Chowdhury AM, Anwer S, Begum M, Eva KN, Shahnaz F. Effects of insulin treated Established Diabetes Mellitus on the volume of placental parenchyma and weight of the neonate. Bangladesh J Anat. 2009;7(1):45-48.
18. Verma R, Mishra S, Kaul M. Cellular changes in placenta in pregnancies complicating with diabetes. Int J Morphol. 2010;28(1):259-264.
19. Evers IM, de Valk HW, Mol BW, TerBraak EW, Visser GH. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia. 2002;45:1484-1489. doi: 10.1007/ s00125-002-0958-7
20. Bane AL, Gillan JE. Massive perivillousfibrinoid causing recurrent placental failure. BJOG. 2003;110: 292-5.
21. Odar E, Wandabwa J, Kiondo P. Maternal and fetal outcome of gestational diabetes mellitus in Mulago Hospital, Uganda. Afr Health Sci. 2004;4(1):9-14.
22. Janson T, Certin I, Powell TL, Desoye G, Radaelli T, Ericsson A, et al. Placental transport and metabolism in fetal overgrowth, A workshop report. Placenta. 2006;27(A):109-113.
23. Persson B, Stangenberg M, Hanson U, Norlander E. Gestational Diabetes Mellitus (GDM): Comparitive evaluation of two treatment regimens; Diet versus insulin and diet. Diabetes. 1985;34(2):101-105.
24. Wong VW, Jalaluddin B. Gestational diabetes mellitus: Who requires insulin therapy? Aust NZ J Obstet Gynecol. 2011;51(5):432-436. doi: 10.1111/j.1479.828x2011.01329.x
25. Farooq MU, Ayaz A, Ali Bahool A, Ahmed I. Maternal and neonatal outcomes in gestational diabetes mellitus. Int J Endocrinol Metab. 2007;3:109-115.